2023
Health disparities in metastatic hormone-sensitive prostate cancer (mHSPC) presentations and outcomes among Hispanic Americans (HA) versus non-Hispanic Whites (NHW)., Armaan Dhaliwal MD (Article)
Engraftment syndrome after allogeneic stem cell transplantation: a systematic review and meta-analysis., Ghada ElGohary; Amir Toor MD; and Usama Gergis MD, MBA (Article)
Phase II, Single Arm, Open Label, Single Center Study of Obinutuzumab and Ibrutinib in the Front Line Treatment of Indolent B-Cell Non-Hodgkin Lymphomas, Joanne Filicko-O'Hara (Article)
Impact of Head and Neck Cancer Diagnosis and Treatment on Patient-Partner Intimacy., Michele Fiorella, Angela Alnemri, Sarah Sussman, Anusha Koka, Jennifer Johnson, David Cognetti, Joseph Curry, Leila Mady, Brooke Worster, Amy E Leader, and Adam Luginbuhl (Article)
Patient-Important Needs and Goals Related to Nutrition Interventions during Cancer Treatment., Emily Foecke Munden, Mackenzie Kemp, Amanda Guth, Anna Marie Chang, Brooke Worster, Iyaniwura Olarewaju, Melissa Denton, and Kristin L Rising (Article)
EP04.02-04 Screening Success: A Review of Outcomes from Lehigh Valley Health Network’s Multi-Disciplinary Lung Cancer Screening Program, Eliot L. Friedman MD, Timothy Johnson MD, Andrea Dally CRNP, Kenneth Cavorsi MD, Richard S. Chang MD, Dennis Sopka MD, C. Gerard Petersen MD, Frank Sperrazza DO, and Dylan Soller DO (Article)
MECHANICAL CIRCULATORY SUPPORT-ASSISTED COMPLEX PCI WITH USE OF NOVEL INTRAVASCULAR LITHOTRIPSY SHOCKWAVE BALLOON, Boula Gattas (Article)
ENDOVASCULAR COIL EMBOLIZATION OF A VERY LARGE - 4.6CM HYPOGASTRIC ARTERY ANEURYSM - A CASE REPORT, Boulas Gattas (Article)
273 - Outcomes for Anti-CD19+ Chimeric Antigen Receptor T (CAR-T) Cell Therapy for Non Hodgkin Lymphoma (NHL) across a Large Community Transplant and Cellular Therapy Network, Usama Gergis MD, MBA (Article)
Early results from a phase 1, multicenter trial of PSCA-specific GoCAR T cells (BPX-601) in patients with metastatic castration-resistant prostate cancer (mCRPC)., Usama Gergis MD, MBA (Article)
Phase 1 trial of LYL797, a ROR1-targeted CAR T-cell therapy enhanced with genetic and epigenetic reprogramming, in advanced triple-negative breast cancer (TNBC) and non-small cell lung cancer (NSCLC), Usama Gergis MD, MBA (Article)
Feasibility of a Text Messaging-Integrated and Chatbot-Interfaced Self-Management Program for Symptom Control in Patients With Gastrointestinal Cancer Undergoing Chemotherapy: Pilot Mixed Methods Study., Sameh Gomaa, James Posey, Babar Bashir, Atrayee Basu Mallick, Eleanor Vanderklok, Max Schnoll, Tingting Zhan, and Kuang-Yi Wen (Article)
Phase 3 Trial of Selpercatinib in Advanced, Julien Hadoux, Rossella Elisei, Marcia S Brose, Ana O Hoff, Bruce G Robinson, Ming Gao, Barbara Jarzab, Pavel Isaev, Katerina Kopeckova, Jonathan Wadsley, Dagmar Führer, Bhumsuk Keam, Stéphane Bardet, Eric J Sherman, Makoto Tahara, Mimi I Hu, Ravinder Singh, Yan Lin, Victoria Soldatenkova, Jennifer Wright, Boris Lin, Patricia Maeda, Jaume Capdevila, and Lori J Wirth (Article)
A Longitudinal Observational Study of Medical Cannabis Use and Polypharmacy among Patients Presenting to Dispensaries in Pennsylvania., Emily R Hajjar, Allison Herens, Erin L Kelly, Kayla Madden, Jessica M Lungen, and Brooke K Worster (Article)
High dose valacyclovir for cytomegalovirus prophylaxis following allogeneic hematopoietic cell transplantation., Kelly G Hawks, Amanda Fegley, Roy T Sabo, Catherine H Roberts, and Amir Toor MD (Article)
The Impact of an Educational Video in Arabic Language on Patients' Knowledge and Attitudes Towards Genetic Testing for Cancer Therapy., Dana Hazimeh, Reem Younes, Talar Telvizian MD, Rami Mahfouz, and Deborah Mukherji (Article)
SARS-CoV-2 vaccination in the first year after allogeneic hematopoietic cell transplant: a prospective, multicentre, observational study., Joshua A Hill, Michael J Martens, Jo-Anne H Young, Kavita Bhavsar, Jianqun Kou, Min Chen, Lik Wee Lee, Aliyah Baluch, Madhav V Dhodapkar, Ryotaro Nakamura, Kristin Peyton, Zainab Shahid, Paul Armistead, Peter Westervelt, John McCarty, Joseph McGuirk, Mehdi Hamadani, Susan DeWolf, Kinga Hosszu, Elad Sharon, Ashley Spahn, Amir Toor MD, Stephanie Waldvogel, Lee M Greenberger, Jeffery J Auletta, Mary M Horowitz, Marcie L Riches, and Miguel-Angel Perales (Article)
Plasmacytic neoplasm in a patient with chronic Immunosuppression: an unusual clinical presentation as shoulder mass, Alisha Hossain DO, Emily C. Skutnik DO, Rayna Abraham, Robert V. Decker MD, Mini G. Abraham MD, and Eliot L. Friedman MD (Poster)
Effect of a MUC5AC Antibody (NPC-1C) Administered With Second-Line Gemcitabine and Nab-Paclitaxel on the Survival of Patients With Advanced Pancreatic Ductal Adenocarcinoma: A Randomized Clinical Trial., Brandon M Huffman, Atrayee Basu Mallick, Nora K Horick, Andrea Wang-Gillam, Peter Joel Hosein, Michael A Morse, Muhammad Shaalan Beg, Janet E Murphy, Sharon Mavroukakis, Anjum Zaki, Benjamin L Schlechter, Hanna Sanoff, Christopher Manz, Brian M Wolpin, Philip Arlen, Jill Lacy, and James M Cleary (Article)
Integrating electronic geriatric assessment and frailty screening for adults with acute myeloid leukemia to drive personalized treatment decisions., Omer Hassan Jamy, Margaret Kasner, Sarah Wall, Stacey Ingram, D 'Ambra Dent, William N Dudley, Leah Dudley, Julie M Scott, and Debra Wujcik (Article)
Analysis of Systems of Care and Outcomes for Stage III Melanoma Patients at Lehigh Valley Topper Cancer Institute (2014-2019), Aidan Johnson and Suresh G. Nair MD (Poster)
Improved Overall Well-Being After Breast Conserving Therapy Using Three-Dimensional Bioabsorbable Markers and Tissue Rearrangement, a Single Institution's Preliminary Experience., Rebecca M Jordan, Monica Rebielak, Kelly Johnson, Marcus Fluck, and Jacqueline Oxenberg DO (Article)
A Phase Ib/II Study Evaluating Navitoclax after Failure of Hypomethylating Agent and Venetoclax for Treatment of Relapsed or Refractory High-Risk Myelodysplastic Syndrome, M Kasner (Article)
Time to Treatment for Patients with Suspected Acute Promyelocytic Leukemia (APL), M Kasner (Article)
Tumor Lysis Syndrome in Patients with AML Initiated on Venetoclax-Based Treatment without a Dose Ramp-up, M Kasner (Article)
207P Palbociclib (P) in patients (pts) with solid tumors with CDK4 or CDK6 amplification (amp): Results from the Targeted Agent and Profiling Utilization Registry (TAPUR) study, Maged Khalil MD, M Rothe, P K. Mangat, E Garrett- Mayer, K F. Mileham, E R. Ahn, H L. Duvivier, L C. Farrington, M Akce, D Behl, P J. Gold, V K. Chiu, N Vijayvergia, C Calfa, A Gaba, F Meric-Bernstam, S M. Schetze, A Gregory, S Halabi, and R L. Schilsky (Article)
Immunotherapy May Improve Tumor Sensitivity to Palliative Chemotherapy in Platinum Resistant Ovarian Cancer., Rachel Kinney DO, Suresh G. Nair MD, Christine H. Kim MD, M Bijoy Thomas MD, and Martin DelaTorre DO (Article)
Larotrectinib efficacy and safety in adult patients with tropomyosin receptor kinase fusion sarcomas., Shivaani Kummar, Lin Shen, David S Hong, Ray McDermott, Vicki L Keedy, Michela Casanova, George D Demetri, Afshin Dowlati, Soledad Gallego Melcón, Ulrik N Lassen, Serge Leyvraz, Tianshu Liu, Victor Moreno, Jyoti Patel, Tejas Patil, Atrayee Basu Mallick, Nuno Sousa, Makoto Tahara, David S Ziegler, Ricarda Norenberg, Pierre Arvis, Nicoletta Brega, Alexander Drilon, and Daniel S W Tan (Article)
Brain Metastases With Malignant Peritoneal Mesothelioma: Never Reported Before., Darshan Lal MD, Merissa Misiura MD, Waqas Adeel, and Rizwan Tariq MD (Article)
Identification of dual STRN-NTRK2 rearrangements in a high grade sarcoma, with good clinical response to first-line larotrectinib therapy., Ruihe Lin, Atrayee Basu Mallick, Zi-Xuan Wang, Scot Andrew Brown, Bo Lu, and Wei Jiang (Article)
SIO-ASCO guideline on integrative medicine for cancer pain management: implications for racial and ethnic pain disparities., Kevin T Liou, Rebecca Ashare, Brooke Worster, Katie F Jones, Katherine A Yeager, Amanda M Acevedo, Rebecca Ferrer, and Salimah H Meghani (Article)
The Correlation of Thyroid Hormone Levels and Anti-Thyroidal Drugs on Thyroid Size, Weight, and Ease of Surgical Dissection for Thyroidectomy for Graves' Disease., Kelcie Lushefski MD, Mary Wolf, James Dove, Marcus Fluck, and Jacqueline Oxenberg DO (Article)
Population Pharmacokinetics and Exposure-Response Analysis for the Phase 3 COSMIC-311 Trial of Cabozantinib for Radioiodine-Refractory Differentiated Thyroid Cancer., Neang S Ly, Jing Li, Raffaella Faggioni, Lorin K Roskos, and Marcia S Brose (Article)
A Phase Ib/II Study of Lenvatinib and Pembrolizumab in Advanced Endometrial Carcinoma (Study 111/KEYNOTE-146): Long-Term Efficacy and Safety Update., Vicky Makker, Carol Aghajanian, Allen L Cohn, Margarita Romeo, Raquel Bratos, Marcia S Brose, Mark Messing, Lea Dutta, Corina E Dutcus, Jie Huang, Emmett V Schmidt, Robert Orlowski, and Matthew H Taylor (Article)
Genetic Referrals, Appointments and Testing for BRCA Mutation in Ovarian Cancer Patients from 2019 to 2022, Julia Mandarino; Melissa Kratz RN, MSN, AOCN; Samantha Carr MS, LGCG; Savitri Skandan MD; and Christine H. Kim MD (Poster)
Kikuchi-Fujimoto Disease, Muhammad Masab, Natalya Surmachevska, and Hafsa Farooq MD (Book Chapter)
Perioperative opioids and survival outcomes in resectable head and neck cancer: A systematic review., Eric V Mastrolonardo, Derek S Mann, Harleen K Sethi, Bo H Yun, Elliott M Sina, Maria Armache, Brooke Worster, Christopher E Fundakowski, and Leila J Mady (Article)
A rare metastatic mesenteric malignant PEComa with TSC2 mutation treated with palliative surgical resection and nab-sirolimus: a case report., Luke Meredith, Timothy Chao, Avinoam Nevler, Atrayee Basu Mallick, Rajan K Singla, Peter A McCue, Wilbur B Bowne, and Wei Jiang (Article)
Association of Pancreatic Adenocarcinoma Location With DNA Damage Response Status and Response to Platinum-Based Therapy., Ida Micaily, Edik M Blais, Randi Carhart, Sophia Lam, Steven J Cohen, Shawna J Cannaday, David Halverson, Lynn M Matrisian, Patricia DeArbeloa, Dzung Thach, Emanuel Petricoin, Michael J Pishvaian, Harish Lavu, Charles J Yeo, and Atrayee Basu Mallick (Article)
TOMM20 as a Potential Prognostic Biomarker in Chordoma: Results From a High-Volume, Single-Center Study., Ida Micaily, Sherry Lee, Atrayee Basu Mallick, Tingting Zhan, Raymond O'Neill, Stacey Gargano, Bryan Hozack, Sameep Thapa, Ubaldo Martinez-Outschoorn, John Abraham, and Wei Jiang (Article)
Physician knowledge, practice patterns, and barriers encountered regarding guideline-concordant use of bone modifying agents for prostate cancer., Aaron P Mitchell, Sonia Persaud, Paul Palyca MD, Andrew Salner, Azeez Farooki, Jamie S Ostroff, Michael J Morris, and Susan Chimonas (Article)
Barriers to guideline-concordant use of bone modifying agents for prostate cancer., A P. Mitchell, S Persaud, S Chimonas, A Salner, Paul Palyca MD, A Farooki, J Ostroff, and M J. Morris (Article)
Oncolytic DNX-2401 virotherapy plus pembrolizumab in recurrent glioblastoma: a phase 1/2 trial., Farshad Nassiri, Vikas Patil, Leeor S Yefet, Olivia Singh, Jeff Liu, Rachel M A Dang, Takafumi N Yamaguchi, Mariza Daras, Timothy F Cloughesy, Howard Colman, Priya U Kumthekar, Clark C Chen, Robert Aiken, Morris D Groves, Shirley S Ong, Rohan Ramakrishna, Michael A Vogelbaum, Simon Khagi, Thomas Kaley, Jason M Melear, David M Peereboom, Analiz Rodriguez, Maxim Yankelevich, Suresh G. Nair MD, Vinay K Puduvalli, Kenneth Aldape, Andrew Gao, Álvaro López-Janeiro, Carlos E de Andrea, Marta M Alonso, Paul Boutros, Joan Robbins, Warren P Mason, Adam M Sonabend, Roger Stupp, Juan Fueyo, Candelaria Gomez-Manzano, Frederick F Lang, and Gelareh Zadeh (Article)
Diffuse large B-cell lymphoma presenting as implantable cardioverter-defibrillator pocket swelling: A case report., Farah Olleik, Talar Telvizian MD, Steven Liskov, Bahij Kreidieh, and Douglas Esberg (Article)
A Phase I Trial of Sirolimus with "7&3" Induction Chemotherapy in Patients with Newly Diagnosed Acute Myeloid Leukemia., Neil Palmisiano, Grace Jeschke, Lindsay Wilde, Onder Alpdogan, Matthew Carabasi, Joanne Filicko-O'Hara, Dolores Grosso, Thomas Klumpp, Ubaldo Martinez, John Wagner, Martin P Carroll, Alexander Perl, and Margaret Kasner (Article)
Randomized, phase II, placebo-controlled trial of nintedanib for the treatment of radiation pneumonitis., Andreas Rimner, Zachary R Moore, Stephanie Lobaugh, Alexander Geyer, Daphna Y Gelblum, Raja-Elie E Abdulnour, Annemarie F Shepherd, Narek Shaverdian, Abraham J Wu, John Cuaron, Jamie E Chaft, Marjorie G Zauderer, Juliana Eng, Gregory J Riely, Charles M Rudin, Nicholas Vander Els, Mohit Chawla, Megan McCune, Henry Li, David R Jones, Dennis Sopka MD, Charles B Simone, Raymond Mak, Gerald L Weinhouse, Zhongxing Liao, Daniel R Gomez, Zhigang Zhang, and Paul K Paik (Article)
A Prioritized Patient-Centered Research Agenda to Reduce Disparities in Telehealth Uptake: Results from a National Consensus Conference., Kristin L Rising, Mackenzie Kemp, Amy E Leader, Anna Marie Chang, Andrew J Monick, Amanda Guth, Tracy Esteves Camacho, Gregory Laynor, and Brooke Worster (Article)
Copper Deficiency Mimicking Myelodysplastic Syndrome: Zinc Supplementation in the Setting of COVID-19., Maya Rosenberg, Sameep Thapa, Chetan Jeurkar, and Margaret Kasner (Article)
The Efficacy of Axillary Reverse Mapping for the Prevention of Lymphedema., Amanda E Ruffino, Joshua D Madera, Makayla M Dearborn, Katie Frank, and Jacqueline Oxenberg DO (Article)
Phase II randomised, double-blind study of mFOLFIRINOX plus ramucirumab versus mFOLFIRINOX plus placebo in advanced pancreatic cancer patients (HCRN GI14-198)., Walid L Shaib, Rupji Manali, Yuan Liu, Bassel El-Rayes, Patrick Loehrer, Bert O'Neil, Steven Cohen, Tina Khair, Erwin Robin, Timothy Huyck, and Tanios Bekaii-Saab (Article)
TUMOR LYSIS SYNDROME IN PATIENT WITH HEPATOCELLULAR CARCINOMA AFTER CHEMOEMBOLIZATION, Chun Siu, Darshan Lal MD, and Muhammad A. Rizvi MD (Article)
Paclitaxel With or Without Cixutumumab as Second-Line Treatment of Metastatic Esophageal or Gastroesophageal Junction Cancer: A Randomized Phase II ECOG-ACRIN Trial., Shannon Stockton, Paul Catalano, Steven J Cohen, Barbara A Burtness, Edith P Mitchell, Efrat Dotan, Sam J Lubner, Pankaj Kumar, Mary F Mulcahy, George A Fisher, Theodore L Crandall, and Al Benson (Article)
Health-related quality-of-life analyses from a multicenter, randomized, double-blind phase 2 study of patients with differentiated thyroid cancer treated with lenvatinib 18 or 24 mg/day., Matthew H Taylor, Sophie Leboulleux, Yury Panaseykin, Bhavana Konda, Christelle de La Fouchardiere, Brett G M Hughes, Andrew G Gianoukakis, Young Joo Park, Ilia Romanov, Monika K Krzyzanowska, Diana Garbinsky, Bintu Sherif, Jie Janice Pan, Terri A Binder, Nicholas Sauter, Ran Xie, and Marcia S Brose (Article)
Development and validation of an integrative pan-solid tumor predictor of PD-1/PD-L1 blockade benefit., Scott A Tomlins, Nickolay A Khazanov, Benjamin J Bulen, Daniel H Hovelson, Melissa J Shreve, Laura E Lamb, Marc R Matrana, Mark E Burkard, Eddy Shih-Hsin Yang, William Jeffery Edenfield, E Claire Dees, Adedayo A Onitilo, Michael Thompson, Gary L Buchschacher, Alan M Miller, Alexander Menter, Benjamin Parsons, Timothy Wassenaar, Leon C Hwang, J Marie Suga, Robert Siegel, William Irvin, Suresh G. Nair MD, Jennifer N Slim, Jamal Misleh, Jamil Khatri, Gregory Masters, Sachdev Thomas, Malek Safa, Daniel M Anderson, Kat Kwiatkowski, Khalis Mitchell, Tina Hu-Seliger, Stephanie Drewery, Andrew Fischer, Komal Plouffe, Eric Czuprenski, Jennifer Hipp, Travis Reeder, Hana Vakil, D Bryan Johnson, and Daniel R Rhodes (Article)
258 - Utilizing Biomarkers, CRP and Ferritin, to Predict the Development of Cytokine Release Syndrome in Patients Receiving Chimeric Antigen Receptor Cell Therapy, Amir Toor MD (Article)
413 - To CD16 or Not to CD16: Phenotypic Analysis of NK Cell Reconstitution after Myeloablative HLA Matched Unrelated HCT By CD16 Subpopulations, Amir Toor MD (Article)
8 - Increased Donor Inhibitory KIR Improve Survival Following HLA Matched Unrelated Donor HCT in Pediatric Acute Leukemia: Subgroup Analysis, Amir Toor MD (Article)
Cell-free next-generation sequencing impacts diagnosis and antimicrobial therapy in immunocompromised hosts: A retrospective study., Nicole C Vissichelli, Megan K Morales, Bharadhwaj Kolipakkam, Alexandra Bryson, Roy T Sabo, and Amir Toor MD (Article)
A phase I study of the combination of palbociclib and dexamethasone for the treatment of relapsed or refractory B-cell acute lymphoblastic leukemia., Lindsay Wilde, Patrizia Porazzi, Rossana Trotta, Marco De Dominici, Neil Palmisiano, Gina Keiffer, Kaitlin Rancani, Kathryn Yingling, Bruno Calabretta, and Margaret Kasner (Article)
Defining and implementing meaningful advance care planning, B Worster (Article)
Interactive music therapy for chronic pain management in people with advanced cancer: A mechanistic study., B Worster (Article)
The impact of music therapy on opioid use in cancer survivors with chronic pain., B Worster (Article)
Clinician Attitudes, Training, and Beliefs About Cannabis: An Interprofessional Assessment., Brooke Worster, Rebecca L Ashare, Emily Hajjar, Greg Garber, Kelsey Smith, and Erin L Kelly (Article)
Increasing equitable access to telehealth oncology care in the COVID-19 National Emergency: Creation of a telehealth task force., Brooke Worster, Lauren Waldman, Gregory Garber, Tingting Zhan, AnaMaria Lopez, Olivia Trachtenberg, Nathan Handley, Kristin L Rising, Valerie Csik, and Amy Leader (Article)
Allogeneic haematopoietic cell transplants as dynamical systems: influence of early-term immune milieu on long-term T-cell recovery., Viktoriya Zelikson, Roy Sabo, Myrna Serrano, Younus Aqeel, Savannah Ward, Taha Al Juhaishi, May Aziz, Elizabeth Krieger, Gary Simmons, Catherine Roberts, Jason Reed, Gregory Buck, and Amir Toor MD (Article)
2022
TKIs beyond immunotherapy predict improved survival in advanced HCC., Samantha Armstrong, Tina Roy, Bhavana Pendurthi Singh MD, Monika Kulasekaran, Fatima Shaukat, Xue Geng, Hongkun Wang, Petra Prins, Reena C Jha, Marion L Hartley, and Aiwu Ruth He (Article)
Characterizing anxiety, pain, sleep, and quality of life among patients in a state Medical Marijuana Program., Rebecca L Ashare, Erin Kelly, Emily R Hajjar, Swechhya Pant, Salimah H Meghani, and Brooke Worster (Article)
NSABP FC-10: A phase Ib study of pembrolizumab (pembro) in combination with pemetrexed (pem) and oxaliplatin (oxali) in patients with chemo-refractory metastatic colorectal cancer (mCRC)., A Basu Mallick (Article)
Phase 1b study of RGX-202-01, a first-in-class oral inhibitor of the SLC6A8/CKB pathway, in combination with FOLFIRI and bevacizumab (BEV) in second-line advanced colorectal cancer (CRC), A Basu Mallick (Article)
Co-management strategies for acute myeloid leukemia patients in the community setting., Christopher Benton, Michael R Grunwald, Hana Safah, and Margaret Kasner (Article)
Risk stratification after recurrence of human papillomavirus (HPV)-related and non-HPV-related oropharyngeal cancer: Secondary analysis of NRG Oncology RTOG 0129 and 0522., Elaine O Bigelow, Jonathan Harris, Carole Fakhry, Maura L Gillison, Phuc Felix Nguyen-Tân, David I Rosenthal, Steven J Frank, Suresh G. Nair MD, Houda Bahig, John A Ridge, Jimmy Caudell, Craig Donaldson, Bradley T Clifford, George Shenouda, Michael J Birrer, Yuhchyau Chen, and Quynh-Thu Le (Article)
Smoking and Its Prognostic Effect on Survival in Patients with TP53 Mutated MDS, Xia Bi MD, MS (Article)
The prognostic impact of cigarette smoking on survival in acute myeloid leukemia with TP53 mutations and/or 17p deletions., Xia Bi MD, MS; Zachary French; Neil Palmisiano; Kuang-Yi Wen; and Lindsay Wilde (Article)
Shared Decision-Making in Managing Breakthrough Cancer Pain in Patients With Advanced Cancer., Jeannine M Brant, Debra Wujcik, William N Dudley, Alison Petok, Brooke Worster, Diane Jones, Kim Bosket, Christian Brady, and Carrie Tompkins Stricker (Article)
Alliance A071401: Phase II Trial of Focal Adhesion Kinase Inhibition in Meningiomas With Somatic, Priscilla K Brastianos, Erin L Twohy, Elizabeth R Gerstner, Timothy J Kaufmann, A John Iafrate, Jochen Lennerz, Suriya Jeyapalan, David E Piccioni, Varun Monga, Camilo E Fadul, David Schiff, Jennie W Taylor, Sajeel A Chowdhary, Chetan Bettegowda, George Ansstas, Macarena De La Fuente, Mark D Anderson, Nicole Shonka, Denise Damek, Jose Carrillo, Lara J Kunschner-Ronan, Rekha Chaudhary, Kurt A Jaeckle, Francis M Senecal, Thomas Kaley, Tara Morrison MD, Alissa A Thomas, Mary R Welch, Fabio Iwamoto, David Cachia, Adam L Cohen, Shivangi Vora, Michael Knopp, Ian F Dunn, Priya Kumthekar, Jann Sarkaria, Susan Geyer, Xiomara W Carrero, Maria Martinez-Lage, Daniel P Cahill, Paul D Brown, Caterina Giannini, Sandro Santagata, Frederick G Barker, and Evanthia Galanis (Article)
A first-in-human phase 1 study of the next-generation RET inhibitor, LOXO-260, in RET inhibitor refractory patients with RET-altered cancers (trial in progress), M Brose (Article)
Clinical application of precision medicine among oncologists: A case study in RET-targeted therapy., M Brose (Article)
Pralsetinib in patients (pts) with advanced or metastatic RET-altered thyroid cancer (TC): Updated data from the ARROW trial., M Brose (Article)
A Randomized Study of Lenvatinib 18 mg vs 24 mg in Patients With Radioiodine-Refractory Differentiated Thyroid Cancer., Marcia S Brose, Yury Panaseykin, Bhavana Konda, Christelle de la Fouchardiere, Brett G M Hughes, Andrew G Gianoukakis, Young Joo Park, Ilia Romanov, Monika K Krzyzanowska, Sophie Leboulleux, Terri A Binder, Corina Dutcus, Ran Xie, and Matthew H Taylor (Article)
Mitogen-Activated Protein Kinase Inhibitor Selumetinib Fails to Increase the Complete Response Rate of Radioactive Iodine Alone in High-Risk Differentiated Thyroid Cancer: Lessons From the Phase III ASTRA Study., Marcia S Brose, Daniel A Pryma, and Kate L Newbold (Article)
Cabozantinib for previously treated radioiodine-refractory differentiated thyroid cancer: Updated results from the phase 3 COSMIC-311 trial., Marcia S Brose, Bruce G Robinson, Steven I Sherman, Barbara Jarzab, Chia-Chi Lin, Fernanda Vaisman, Ana O Hoff, Erika Hitre, Daniel W Bowles, Suvajit Sen, Jennifer W Oliver, Kamalika Banerjee, Bhumsuk Keam, and Jaume Capdevila (Article)
Multikinase Inhibitors for the Treatment of Asymptomatic Radioactive Iodine-Refractory Differentiated Thyroid Cancer: Global Noninterventional Study (RIFTOS MKI)., Marcia S Brose, Johannes W A Smit, Chia-Chi Lin, Masayuki Tori, Daniel W Bowles, Francis Worden, Daniel Hueng-Yuan Shen, Shih-Ming Huang, Hui-Jen Tsai, Maria Alevizaki, Robin P Peeters, Shunji Takahashi, Pavel Rumyantsev, Rongjin Guan, Svetlana Babajanyan, Kirhan Ozgurdal, Iwao Sugitani, Fabian Pitoia, and Livia Lamartina (Article)
Dose determination and pharmacokinetics (PK) of pralsetinib: Results from the phase I ARROW study, M S. Brose (Article)
Intra-patient (Pt) comparison from larotrectinib (Laro) clinical trials in tropomyosin receptor kinase (TRK) fusion cancer: An expanded dataset, M S. Brose (Article)
Updated ARROW data: Pralsetinib in patients (pts) with advanced or metastatic RET-altered thyroid cancer (TC), M S. Brose (Article)
Updated efficacy and safety of larotrectinib in patients with TRK fusion salivary gland tumours, M S. Brose (Article)
Updated efficacy and safety of larotrectinib in patients with TRK fusion salivary gland tumours, M S. Brose (Article)
Deep Margins Melanoma: How Deep Is Deep Enough?, Megan L Burger, James M Haggerty, Shengxuan Wang, and Jacqueline Oxenberg DO (Article)
Comparative effectiveness of larotrectinib and entrectinib for TRK fusion cancer., Josh J Carlson, Antoine Italiano, Marcia S Brose, Noah Federman, Ulrik Lassen, Shivaani Kummar, and Sean D Sullivan (Article)
Establishment and characterization of prostate organoids from treatment-naïve patients with prostate cancer., Katia Cheaito, Hisham F Bahmad, Ola Hadadeh, Hiba Msheik, Alissar Monzer, Farah Ballout, Christelle Dagher, Talar Telvizian MD, Nour Saheb, Ayman Tawil, Marwan El-Sabban, Albert El-Hajj, Deborah Mukherji, Mohamed Al-Sayegh, and Wassim Abou-Kheir (Article)
FRACTION-RCC: nivolumab plus ipilimumab for advanced renal cell carcinoma after progression on immuno-oncology therapy., Toni K Choueiri, Harriet Kluger, Saby George, Scott S Tykodi, Timothy M Kuzel, Ruth Perets, Suresh G. Nair MD, Giuseppe Procopio, Michael A Carducci, Vincent Castonguay, Edmund Folefac, Chung-Han Lee, Sebastien J Hotte, Wilson H Miller, Shruti Shally Saggi, Chung-Wei Lee, Heshani Desilva, Prabhu Bhagavatheeswaran, Robert J Motzer, and Bernard Escudier (Article)
Association of pancreatic adenocarcinoma location (head/body/tail) with DDR mutation status and response to platinum-based therapy., S J. Cohen and A Basu Mallick (Article)
Tisagenlecleucel for secondary CNS lymphoma, a case series., Armaan Dhaliwal MD (Article)
Immunophenotypic Differences in Cerebrospinal Fluid and Peripheral Blood Demonstrating Cancer Heterogenicity in Acute Myeloid Leukemia Patient., Chelsea Edirisuriya, Chetan Jeurkar, Bushra Nazir, Mia Belovsky, and Margaret Kasner (Article)
Loss of function STK11 alterations and poor outcomes in non-small-cell lung cancer: Literature and case series of US Veterans., Hafsa Farooq MD, Harold Bien, Victor Chang, Daniel Becker, Yeun-Hee Park, and Susan E Bates (Article)